Contribute Try STAT+ Today

Good morning, everyone, and how are you today? We are doing just fine, thank you, despite the gloomy skies hovering over the muggy Pharmalot campus. After all, as the Morning Mayor taught us long ago: Every new day should be unwrapped like a precious gift. And in times like these, such notions resonate more broadly, yes? So let us proceed on the journey together with a nice cup of stimulation — maple bourbon is the choice today for those who are curious. Meanwhile, here are some tidbits. Hope all goes well, and do keep us in mind when something fascinating pops up. …

The scientist leading the Operation Warp Speed Covid-19 vaccine program will be allowed to remain a government contractor, a decision that permits him to avoid ethics disclosures required of federal employees and maintain his investments in drug makers, The New York Times writes. Two watchdog groups and some Democrats in Congress had called for the Department of Health and Human Services to require that  Moncef Slaoui, a venture capitalist and a former GlaxoSmithKline (GSK) executive, fall under the same ethics rules as federal employees.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!


What is it?

STAT+ is STAT's premium subscription service for in-depth biotech, pharma, policy, and life science coverage and analysis. Our award-winning team covers news on Wall Street, policy developments in Washington, early science breakthroughs and clinical trial results, and health care disruption in Silicon Valley and beyond.

What's included?

  • Daily reporting and analysis
  • The most comprehensive industry coverage from a powerhouse team of reporters
  • Subscriber-only newsletters
  • Daily newsletters to brief you on the most important industry news of the day
  • STAT+ Conversations
  • Weekly opportunities to engage with our reporters and leading industry experts in live video conversations
  • Exclusive industry events
  • Premium access to subscriber-only networking events around the country
  • The best reporters in the industry
  • The most trusted and well-connected newsroom in the health care industry
  • And much more
  • Exclusive interviews with industry leaders, profiles, and premium tools, like our CRISPR Trackr.

Your daily dose of news in health and medicine

Privacy Policy